中国医院用药评价与分析2024，Vol.24Issue(4)：412-416,5.DOI:10.14009/j.issn.1672-2124.2024.04.006
合欢树不同部位挥发油成分及其气相色谱-四极杆飞行时间串联质谱分析
Gas Chromatography-Quadrupole Time-of-Flight Mass Spectrometry Analysis on Chemical Components of Volatile Oil from Different Parts of Albizia Julibrissin Durazz
摘要
Abstract
OBJECTIVE:To analyze the volatile components in different medicinal parts of Albizia Julibrissin Durazz(albiziae flos,Hehuanmi and silktree albizziae)and the relative contents.METHODS:Volatile oil from albiziae flos,Hehuanmi and silktree albizziae was extracted by simultaneous distillation extraction method.Chemical constituents were determined by gas chromatography-quadrupole time-of-flight mass spectrometry(GC-Q/TOF-MS).Compounds were searched and identified through the NIST 14.L database.The relative content of each component was determined by area normalization.RESULTS:A total of 80,61 and 42 components were identified from the volatile oil of albiziae flos,Hehuanmi and silktree albizziae,accounting for 96.44%,97.67%and 93.36%of the total volatile components.The relative percentage of aliphatic compounds in silktree albizziae was higher than that in albiziae flos and Hehuanmi.The relative percentage and quantity of aromatic compounds and terpenoids in silktree albizziae were significantly lower than those in albiziae flos and Hehuanmi.There were 11 components shared by albiziae flos,Hehuanmi and silktree albizziae.There were 25 unique components of albiziae flos,10 unique components of Hehuanmi,and 27 components of silktree albizziae.CONCLUSIONS:GC-Q/TOF-MS technique can be used to analyze and compare the volatile components of albiziae flos,Hehuanmi and silktree albizziae,which provides scientific basis for the rational development and application.关键词
合欢树不同部位/挥发油/同时蒸馏-萃取/气相色谱-四极杆飞行时间串联质谱Key words
Different parts of Albizia Julibrissin Durazz/Volatile oil/Simultaneous distillation extraction/Gas chromatography-quadrupoletime-of-flight mass spectrometry分类
医药卫生引用本文复制引用
冯欣,刘敏,田佳懿,陈丽芳,王林燕,王淑梅..合欢树不同部位挥发油成分及其气相色谱-四极杆飞行时间串联质谱分析[J].中国医院用药评价与分析,2024,24(4):412-416,5.基金项目
国家自然科学基金资助项目(No.81872926) （No.81872926）
北京市属医院科研培育计划项目(No.PZ2019008) （No.PZ2019008）
